Caricamento...
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
HER2 overexpression and anti-HER2 agents represent probably the best story of success of individualized therapy in breast cancer. Due to the important therapeutic implications, the issue under the spotlight has been, since ever, the correct identification of true HER2 positivity on tissue specimens....
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3659312/ https://ncbi.nlm.nih.gov/pubmed/23734345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00129 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|